Road to 2025: How Lumos has diagnosed its place in the market
Stockhead TV
share
Stockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes they’re plotting towards a successful year ahead.
In this episode, Sarah Hughan covers Lumos Diagnostics (ASX:LDX) which develops, manufactures and distributes innovative diagnostic products.
In 2024 Lumos Diagnostics signed a new strategic partnership and established a significant distribution network for one of its own point-of-care tests and is currently working on new product developments.
Tune in to find out what to look out for in 2025.
This video was developed in collaboration with Lumos Diagnostics a Stockhead advertiser at the time of publishing.
The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
Read MoreHealth
